BRIACELL THERAPEUTICS
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. The company's patented immunotherapy Bria-IMT™ is developed from a breast cancer cell line is an immunotherapy approach that directly stimulates the body’s own cancer-fighting cells to attack and destroy breast cancer tumors. It induces an antitumor response both indirectly and directly by stimulating the immune system which collectively boosts the body’s... response. BriaCell achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT™ in a combination with retifanlimab and epacadostat. The company is developing Bria-OTS™, the first “off the shelf” personalized immunotherapy for advanced breast cancer. It is founded in New York, New York in 2004.
BRIACELL THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.briacell.com
Total Employee:
11+
Status:
Active
Contact:
1-888-485-6340
Email Addresses:
[email protected]
Total Funding:
27.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Domain Not Resolving
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.briacell.com
- Host name: 96.0.153.160.host.secureserver.net
- IP address: 160.153.0.96
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "BriaCell Therapeutics"
About Us - BriaCell
About BriaCell. Dedicated to enhance the lives of women with breast cancer with limited therapy options, BriaCell Therapeutics Corp.’s (NASDAQ: BCTX, BCTXW) (TSX-V:BCT) mission has …See details»
Corporate Profile - BriaCell
Corporate Profile. Corporate Profile. BriaCell (NASDAQ: BCTX, BCTXW) (TSX-V:BCT) is an immuno-oncology focused biotechnology company developing targeted and safe approaches …See details»
Presentation & Fact Sheet - BriaCell
BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care.See details»
BriaCell Therapeutics - Crunchbase Company Profile & Funding
BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. The company's patented immunotherapy …See details»
BriaCell Therapeutics Company Description - Stock Analysis
2 days ago BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, …See details»
Briacell Company Profile - Office Locations, Competitors ... - Craft
Sep 12, 2024 Briacell is a clinical-stage biotech company that focuses on immuno-oncology and develops personalized immunotherapy for cancer. It provides drug candidates based on whole …See details»
BriaCell Provides Update to its Board of Directors - GlobeNewswire
Nov 25, 2024 About BriaCell Therapeutics Corp. BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is …See details»
BriaCell Therapeutics - Overview, News & Similar companies
Feb 16, 2022 BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study PHILADELPHIA and VANCOUVER, British Columbia, May 28, 2024 (GLOBE …See details»
About BriaCell - BriaCell
About BriaCell. Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to developing novel immunotherapies to fight cancer and …See details»
BriaCell Announces Availability of Annual General Meeting
5 days ago About BriaCell Therapeutics Corp. BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. More information is available …See details»
Contact Us - BriaCell
BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care.See details»
Briacell Therapeutics Corp (BCT-T) Stock Price and News
Real-time Price Updates for Briacell Therapeutics Corp (BCT-T), along with buy or sell indicators, analysis, charts, historical performance, news and moreSee details»
Vancouver's BriaCell raising $5.5 million for cancer drug - Business …
5 days ago BriaCell Therapeutics Corp. (TSX: BCT,Nasdaq), a Vancouver-Philadelphia biotechnology company with a new cancer drug in clinical trials, plans to raise US$5.5 million …See details»
BriaPro - BriaCell
BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care.See details»
BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off …
Nov 8, 2024 BriaCell’s clinical candidates for next generation breast cancer (Bria-BRES+™) and prostate cancer (Bria-PROS+™) generate robust anti-cancer activity in preclinical …See details»
Corporate Governance - BriaCell
Corporate Office - Canada Suite 300 - Bellevue Centre, 235 -15th Street, West Vancouver, BC V7T 2X1 Tel: 604-921-1810 Fax: 604-921-1898. Corporate Office - USA 2929 Arch Street, 3rd …See details»
BriaCell Announces Availability of Annual General Meeting …
5 days ago BriaCell Therapeutics Corp. PHILADELPHIA and VANCOUVER, British Columbia, Dec. 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) …See details»
Management Team - BriaCell
Dr. Williams is a seasoned biopharmaceutical executive with over 35 years of industry and academic expertise, including significant clinical management in multinational pharmaceutical …See details»
Stock Information - BriaCell
BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care.See details»
BriaCell Adapts Meeting Procedures Amid Postal Strike
4 days ago BriaCell Therapeutics is adapting its annual general meeting procedures due to a postal strike in Canada, offering alternative methods for shareholders to access and vote on …See details»